BearDownAZ's Recent Posts
Title Rating ▲ Company Posted on
Re: Are statins overprescribed? Why the risks and benefits are so complex / Pitavastatin 2 Resverlogix Corp. Dec 04, 2018 08:44PM
Re: Question for Bear 2 Resverlogix Corp. Jan 10, 2017 01:11PM
Re: 2 new upcoming presentations 2 Resverlogix Corp. May 03, 2020 04:55PM
Re: The 3 inflection points: SSRA, Top-Line, Full Data 2 Resverlogix Corp. Sep 10, 2018 09:26AM
Re: AACR 2 Zenith Epigenetics Apr 09, 2019 11:36AM
Re: Actions Speak Louder Than Words 2 Resverlogix Corp. Nov 20, 2016 01:28PM
Re: 2 new upcoming presentations 2 Resverlogix Corp. May 03, 2020 04:59PM
Re: You're right 10bagr, you didn't sway me.... 2 Resverlogix Corp. Feb 01, 2019 04:05PM
Re: Vaccine 2 Resverlogix Corp. Nov 17, 2020 09:46AM
Re: ESC Poster on BETonMACE Design and Baseline Data 2 Resverlogix Corp. Sep 03, 2019 09:44AM
Re: Statistical Considerations 2 Resverlogix Corp. Mar 09, 2018 10:05AM
Re: Patient Years & MACE rate Question 2 Resverlogix Corp. Jul 11, 2019 09:00AM
June 7: Delivering Across the Blood Brain Barrier - Crossing the Final Frontier 2 BIOASIS TECHNOLOGIES INC Apr 25, 2016 07:48AM
Re: Amgen cholesterol drug Repatha "Profound Regression", Dr. Nissen 2 Resverlogix Corp. Nov 15, 2016 01:48PM
Re: Resverlogix Announces Participation at Premier Kidney, Alzheimer’s Disease and Cardiovascular Conferences 2 Resverlogix Corp. Oct 28, 2018 08:33AM
Bioasis Acquires Phase 2 Ready Rare Orphan EGF Assets 2 BIOASIS TECHNOLOGIES INC Jun 21, 2022 08:08AM
Re: RVX 297 publication news from rndtbl from IV 2 Resverlogix Corp. Oct 03, 2017 11:54AM
Re: Lowest volume in a long time? 2 Resverlogix Corp. Dec 18, 2018 10:16AM
Bioasis Announces Allowances of Patent Applications in the U.S. and Europe Relating to xB3 Platform Technology and Key Therapeutic Indications 3 BIOASIS TECHNOLOGIES INC Jun 25, 2019 06:52AM
Re: AMRN Adcom 3 Resverlogix Corp. Aug 08, 2019 09:40PM